These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26868056)

  • 1. Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis.
    Pelucchi S; Galimberti S; Greni F; Rametta R; Mariani R; Pelloni I; Girelli D; Busti F; Ravasi G; Valsecchi MG; Valenti L; Piperno A
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1342-8. PubMed ID: 26868056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis.
    Stickel F; Buch S; Zoller H; Hultcrantz R; Gallati S; Österreicher C; Finkenstedt A; Stadlmayr A; Aigner E; Sahinbegovic E; Sarrazin C; Schafmayer C; Braun F; Erhart W; Nothnagel M; Lerch MM; Mayerle J; Völzke H; Schaller A; Kratzer W; Boehm BO; Sipos B; D'Amato M; Torkvist L; Stal P; Arlt A; Franke A; Becker T; Krawczak M; Zwerina J; Berg T; Hinrichsen H; Krones E; Dejaco C; Strasser M; Datz C; Hampe J
    Hum Mol Genet; 2014 Jul; 23(14):3883-90. PubMed ID: 24556216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors.
    Greni F; Valenti L; Mariani R; Pelloni I; Rametta R; Busti F; Ravasi G; Girelli D; Fargion S; Galimberti S; Piperno A; Pelucchi S
    Ann Hepatol; 2017; 16(3):451-456. PubMed ID: 28425416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
    Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosis.
    Buch S; Sharma A; Ryan E; Datz C; Griffiths WJH; Way M; Buckley TWM; Ryan JD; Stewart S; Wright C; Dongiovanni P; Fracanzani A; Zwerina J; Merle U; Weiss KH; Aigner E; Krones E; Dejaco C; Fischer J; Berg T; Valenti L; Zoller H; McQuillin A; Hampe J; Stickel F; Morgan MY
    Aliment Pharmacol Ther; 2021 Apr; 53(7):830-843. PubMed ID: 33565643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
    Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
    Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PNPLA3 and RNF7 Gene Variants are Associated with the Risk of Developing Liver Fibrosis and Cirrhosis in an Eastern European Population.
    Kupcinskas J; Valantiene I; Varkalaitė G; Steponaitiene R; Skieceviciene J; Sumskiene J; Petrenkiene V; Kondrackiene J; Kiudelis G; Lammert F; Kupcinskas L
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):37-43. PubMed ID: 28338112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosis.
    Duarte TL; Caldas C; Santos AG; Silva-Gomes S; Santos-Gonçalves A; Martins MJ; Porto G; Lopes JM
    Redox Biol; 2017 Apr; 11():157-169. PubMed ID: 27936457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemochromatosis gene HFE Cys282Tyr mutation analysis in a cohort of Northeast German hospitalized patients supports assumption of a North to South allele frequency gradient throughout Germany.
    Meier P; Schuff-Werner P; Steiner M
    Clin Lab; 2005; 51(9-10):539-43. PubMed ID: 16285477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Simple RFLP-Based Method for
    Ogouma-Aworet L; Rabes JP; de Mazancourt P
    Biomed Res Int; 2020; 2020():9396318. PubMed ID: 33457423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
    Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
    Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced phenotypic expression in genetic hemochromatosis with time: Role of exposure to non-genetic modifiers.
    Deugnier Y; Morcet J; Lainé F; Hamdi-Roze H; Bollard AS; Guyader D; Moirand R; Bardou-Jacquet E
    J Hepatol; 2019 Jan; 70(1):118-125. PubMed ID: 30244162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetrance of the C28Y/C282Y genotype of the HFE gene.
    Asberg A; Hveem K; Kannelønning K; Irgens WØ
    Scand J Gastroenterol; 2007 Sep; 42(9):1073-7. PubMed ID: 17710673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes.
    Barton JC; McLaren CE; Chen WP; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN; Adams PC; Phatak PD; Gurrin LC; Phillips JD; Parker CJ; Emond MJ; McLaren GD
    Ann Hepatol; 2018 Aug; 17(5):871-879. PubMed ID: 30145563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rs508487, rs236911, and rs236918 Genetic Variants of the Proprotein Convertase Subtilisin-Kexin Type 7 (
    Vargas-Alarcón G; Pérez-Méndez O; González-Pacheco H; Ramírez-Bello J; Posadas-Sánchez R; Escobedo G; Fragoso JM
    Cells; 2021 Jun; 10(6):. PubMed ID: 34207761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ancestral haplotype markers HLA -A3 and B7 do not influence the likelihood of advanced hepatic fibrosis or cirrhosis in HFE hemochromatosis.
    Olynyk JK; Grainger R; Currie H; Ramm LE; Ramm GA
    Sci Rep; 2023 May; 13(1):7775. PubMed ID: 37179448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma.
    Fargion S; Stazi MA; Fracanzani AL; Mattioli M; Sampietro M; Tavazzi D; Bertelli C; Patriarca V; Mariani C; Fiorelli G
    Blood Cells Mol Dis; 2001; 27(2):505-11. PubMed ID: 11500061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based analysis of the frequency of HFE gene polymorphisms: Correlation with the susceptibility to develop hereditary hemochromatosis.
    Katsarou MS; Latsi R; Papasavva M; Demertzis N; Kalogridis T; Tsatsakis AM; Spandidos DA; Drakoulis N
    Mol Med Rep; 2016 Jul; 14(1):630-6. PubMed ID: 27221532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.